Sign in to continue:

Wednesday, February 25th, 2026

Archer Aviation Inc. SEC Form 8-K Filing Details for February 2026 – Company Information, Stock & Warrants on NYSE

NIL


Disclaimer: The information provided above is based on the contents of Archer Aviation Inc.’s Form 8-K filing dated February 24, 2026. This report contains no new material disclosures or price-sensitive information that could reasonably be expected to affect share values. Investors should always consult official filings and their financial advisors before making any investment decisions.

View Archer Aviation Inc. Historical chart here



Hanover Insurance Group, Inc. 2025 Annual Report | Financials, Business Segments, and XBRL Filings

Hanover Insurance Group, Inc. 2025 Annual 10-K Report: Key Highlights for Investors Hanover Insurance Group, Inc. 2025 Annual 10-K Report: Key Highlights for Investors Summary of Key Points Company Overview: Hanover Insurance Group, Inc....

Valaris Reports Strong Q4 2025 Results, $900M Backlog Increase, and Announces Transocean Merger

Valaris Q4 2025 Earnings: Key Investor Takeaways Valaris Limited Reports Q4 2025 Results: Strong Operational Performance, \$900M Backlog Added, and Pending Transocean Merger Key Points for Investors Exceptional Revenue Efficiency: Achieved 98% revenue efficiency...

Vaxcyte, Inc. 8-K Filing Details, Sales Agreement with Leerink Partners, and Entity Information (2026)

Vaxcyte, Inc. Announces New \$500 Million At-the-Market Equity Offering Agreement Vaxcyte, Inc. Announces New \$500 Million At-the-Market Equity Offering Agreement Key Highlights Vaxcyte, Inc. (NASDAQ: PCVX) enters a new Sales Agreement with Leerink Partners...

   Ad